FII Holdings

BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

NSE : BIOFILCHEMBSE : 524396ISIN CODE : INE829A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE71.79-2.96 (-3.96 %)
PREV CLOSE ( ) 74.75
OPEN PRICE ( ) 73.11
BID PRICE (QTY) 71.79 (500)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 116870
TODAY'S LOW / HIGH ( )71.00 77.95
52 WK LOW / HIGH ( )41.01 78.8
NSE72.15-2.4 (-3.22 %)
PREV CLOSE( ) 74.55
OPEN PRICE ( ) 74.80
BID PRICE (QTY) 72.15 (64)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 315094
TODAY'S LOW / HIGH( ) 71.35 77.60
52 WK LOW / HIGH ( )41.3 79
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.